GEN Exclusives

More »

GEN News Highlights

More »
Nov 10, 2009

Life Technologies Offers Next-Gen Platform to University of Cambridge’s Sequencing Hub

  • Life Technologies is providing three SOLiD™ 3 Plus Systems to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge. The technology will be leveraged in diseases such as cancer, diabetes, and neurological disorders to advance targeted medical resequencing and whole-transcriptome analysis research studies.

    The hub was established with funding from the Medical Research Council and from the University of Cambridge’s Clinical School and NIHR Biomedical Research Centre to accelerate the use of genetic information to help identify new therapies, diagnostics, and preventive strategies.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?